Hemophilia An Opportunity For Personal Empowerment Inc Boulder, CO - 80302

Hemophilia An Opportunity For Personal Empowerment Inc is categorized under Organizations in Boulder, CO .

Hemophilia An Opportunity For Personal Empowerment Inc was established in 0, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Organizations business, which does work in the BOTH market, and is classified as a Organizations, under code number 813410 by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 2881 North Lakeridge Trail, Boulder, Colorado CO 80302 or by phoning (615) 354-1800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Hemophilia An Opportunity For Personal Empowerment Inc
Address: 2881 North Lakeridge Trail, Boulder, Colorado 80302
Phone Number: (615) 354-1800
Annual Revenue (USD): $50.000 to $99.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: Organizations
SIC Code: 8699
NAICS Code: 813410
Share This Business:

Hemophilia An Opportunity For Personal Empowerment Inc was started in 0 to provide professional Organizations under the SIC code 8699 and NAICS code 813410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact for inquiries that concern Hemophilia An Opportunity For Personal Empowerment Inc by calling the company number (615) 354-1800, as your correspondence is most welcome. Additionally, the physical location of the single location of Hemophilia An Opportunity For Personal Empowerment Inc can be found at the coordinates as well as the street address 2881 North Lakeridge Trail in Boulder, Colorado 80302.

For its online presence, you may visit Hemophilia An Opportunity For Personal Empowerment Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.